Patents
Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
05/2009
05/22/2009WO2009064852A1 3-aminosulfonyl substituted indole derivatives and methods of use thereof
05/22/2009WO2009064835A1 4-pyrazolyl-n-arylpyrimidin-2-amines and 4-pyrazolyl-n-heteroarylpyrimidin-2-amines as janus kinase inhibitors
05/22/2009WO2009064800A1 Intermediates and methods for the preparation of epothilones
05/22/2009WO2009064752A2 Heterocyclic derivatives as modulators of ion channels
05/22/2009WO2009064747A2 4(-3-(-2-(phenyl) morpholino)-2-oxopyrrolidin-1-yl)-n-(thiazol-2-yl) benzenesulfon amide derivatives and related compounds as modulators of ion channels for the treatment of pain
05/22/2009WO2009064418A1 Substituted hydroxyethyl amine compounds as beta-secretase modulators and methods of use
05/22/2009WO2009064251A1 Bis-(sulfonylamino) derivatives in therapy 066
05/22/2009WO2009064250A1 Bis-(sulfonylamino) derivatives in therapy 065
05/22/2009WO2009063821A1 Heteroaryloxy quinazoline derivative
05/22/2009WO2009063061A2 Aryl- and heteroarylcarbonyl derivatives of benzomorphanes and related scaffolds, medicaments containing such compounds and their use
05/22/2009WO2009063054A1 Novel bifunctional compounds which inhibit protein kinases and histone deacetylases
05/22/2009WO2009062576A2 Benzimidazoledihydrothiadiazinone derivatives as fructose-1,6-bisphosphatase inhibitors, and pharmaceutical compositions comprising same
05/22/2009WO2009062289A1 Inhibitors of human immunodeficiency virus replication
05/22/2009WO2009062285A1 Inhibitors of human immunodeficiency virus replication
05/22/2009WO2009046010A3 Monomethine dyes
05/22/2009WO2009040755A3 Pyrrole compounds as inhibitors of mycobacteria, synthesis thereof ans intermediates thereto
05/22/2009WO2009010260A3 Condensed anthranilamide insecticides
05/22/2009WO2005020913A3 Formulations, conjugates, and combinations of drugs for the treatment of neoplasms
05/22/2009CA2707418A1 Inhibitors of human immunodeficiency virus replication
05/22/2009CA2705922A1 Novel bifunctional compounds which inhibit protein kinases and histone deacetylases
05/22/2009CA2705755A1 Bis-(sulfonylamino) derivatives in therapy 066
05/22/2009CA2705587A1 3-aminosulfonyl substituted indole derivatives and methods of use thereof
05/22/2009CA2705547A1 Heterocyclic derivatives as modulators of ion channels
05/22/2009CA2705390A1 Benzimidazoledihydrothiadiazinone derivatives as fructose-1,6-bisphosphatase inhibitors, and pharmaceutical compositions comprising same
05/22/2009CA2705370A1 Heteroaryloxy quinazoline derivatives
05/22/2009CA2705336A1 Heterocyclic derivatives as modulators of ion channels
05/22/2009CA2705318A1 Inhibitors of human immunodeficiency virus replication
05/22/2009CA2704628A1 Aryl- and heteroarylcarbonyl derivatives of benzomorphanes and related scaffolds, medicaments containing such compounds and their use
05/22/2009CA2704599A1 4-pyrazolyl-n-arylpyrimidin-2-amines and 4-pyrazolyl-n-heteroarylpyrimidin-2-amines as janus kinase inhibitors
05/21/2009US20090131475 Compositions and methods for the treatment of metabolic disorders
05/21/2009US20090131461 Quinoline and quinoxaline derivatives as inhibitors of kinase enzymatic activity
05/21/2009US20090131440 Heterocyclic derivatives as modulators of ion channels
05/21/2009US20090131439 Therapeutic agent for chronic obstructive pulmonary disease
05/21/2009US20090131435 Heterocyclic inhibitors of mek and methods of use
05/21/2009US20090131428 Benzooxazole-4,7-dione, derivatives and their use as cdc25 phosphate inhibitors
05/21/2009US20090131411 monoamidino-containing compounds having good bioavailability and/or solubility, used as potent and specific inhibitors of blood coagulation in mammals, and as therapeutic agents for disease states characterized by coagulation disorders
05/21/2009US20090131401 Transcription factor modulating compounds and methods of use thereof
05/21/2009US20090131397 Estrogen modulators
05/21/2009US20090130077 Substituted benzoazole pde4 inhibitors for treating inflammatory, cardiovascular and cns disorders
05/21/2009US20090130076 Substituted benzoazole pde4 inhibitors for treating pulmonary and cardiovascular disorders
05/20/2009EP2060571A1 Insecticide iminoheterocycles
05/20/2009EP2060570A2 Azabicyclo(3.1.0) hexane derivatives useful as modulators of dopamine D3 receptors
05/20/2009EP2060565A1 Novel bifunctional compounds which inhibit protein kinases and histone deacetylases
05/20/2009EP2060260A1 Therapeutic agents useful for treating pain
05/20/2009EP2060258A1 Use of CRTH2 antagonist compounds in therapy
05/20/2009EP2059507A2 Ep2 agonists
05/20/2009EP1365760B1 Preparations and use of an ah receptor ligand, 2-(1'h-indole-3'-carbonyl)-thiazole-4-carboxylic acid methyl ester
05/20/2009CN101437817A Novel process for production of 5-{2-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]-ethyl}-6-chloro-1,3-dihydro-2H-indol-2-one (ziprasidone)
05/20/2009CN101437816A 2-aminopyridine analogs as glucokinase activators
05/20/2009CN101437803A Dibenzyl amine derivatives as CETP inhibitors
05/20/2009CN101437512A Glucokinase activators
05/20/2009CN101434585A Amide derivatives as GK activators
05/20/2009CN100489056C 有机电致发光元件 Organic electroluminescent element
05/20/2009CN100488963C New thiobizole formanide derivative and its synthesis process and bioactivity
05/20/2009CN100488962C Derivative of thiadiazoles containing cyclo oxdiazole, synthetic method, and biological activity
05/20/2009CN100488960C 2-substituted quinolone compound and use in pharmacy
05/20/2009CN100488958C 3-substituted-4-pyrimidone derivatives
05/20/2009CN100488955C New compound with activity of inducing secondary metabolism of Hypericum plant
05/20/2009CN100488923C Double-loop coil organic compounds and electric-field luminescent devices
05/20/2009CN100488506C 5-membered heterocycle derivatives, production thereof and use as medicaments
05/20/2009CN100488504C Novel coumarin-amide derivatives and its preparation, its drug composition and use
05/19/2009US7534801 Piperidinylchromen-6-ylsulfonamide compounds as 5-hydroxytryptamine-6 ligands
05/19/2009US7534798 Vanilloid receptor ligands and their use in treatments
05/19/2009US7534794 Certain arylaliphatic and heteroaryl-aliphatic piperazinyl pyrazines and their use in the treatment of serotonin-related diseases
05/19/2009US7534793 (R)-2-{4-[(1H-Indol-2-ylmethyl)-amino]-piperidin-1-yl}-1-(6-methoxyquinolin-4-yl)-ethanol; effective against both gramnegative and grampositive bacteria
05/19/2009US7534784 ligands for Calcitonin gene related peptide; azepinone ligands; migranes; N-[5-(2,3-Difluorophenyl)-1-(2-methoxyethyl)-2-oxopiperidin-3-yl]-4-(2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxamide
05/19/2009US7534593 Crystals of glucokinase and methods of growing them
05/19/2009US7534503 Polythiophenes, furan resins, polypyrroles, organonitrogen polymers
05/19/2009US7534421 Water solubility; photostability; sunscreen agents; ultraviolet radiation B and A absorbers
05/19/2009CA2498047C Novel imidazole compounds as transforming growth factor (tgf) inhibitors
05/19/2009CA2375017C Hydrochloride of fused-heterocycle compound
05/19/2009CA2230931C 4-(oxyalkoxyphenyl)-3-oxy-piperidines for treating heart and kidney insufficiency
05/19/2009CA2211381C Compounds with growth hormone releasing properties
05/14/2009WO2009061761A2 Fungicidal heterocyclic amines
05/14/2009WO2009061498A1 CYCLIC UREA INHIBITORS OF 11β -HYDROXYSTEROID DEHYDROGENASE 1
05/14/2009WO2009060215A1 Polyamides
05/14/2009WO2009060054A1 Triazole derivatives as scd inhibitors
05/14/2009WO2009037357A4 Benzimidazole nf- kappab inhibitors
05/14/2009WO2009031040A3 Compounds with anti-cancer activity
05/14/2009WO2008137816A3 Tricyclic compounds as matrix metalloproteinase inhibitors
05/14/2009WO2008060626A3 Compounds for modulating trpv3 function
05/14/2009WO2008049123A8 2,4-pyrimidinediamine derivatives as inhibitors of jak kinases for the treatment of autoimmune diseases
05/14/2009US20090124809 Process for preparing acyclic hcv protease inhibitors
05/14/2009US20090124808 Process for preparing acyclic hcv protease inhibitors
05/14/2009US20090124668 Cyclic derivatives as modulators of chemokine receptor activity
05/14/2009US20090124667 Novel Dual-Use Peptidase Inhibitors as Prodrugs for a Therapy of Inflammatory and Other Diseases
05/14/2009US20090124660 Piperidine Compounds Useful as Malonyl-CoA Decarboxylase Inhibitors
05/14/2009US20090124629 3-(1,2,4-triazol-3ylalkyl) azabriclo (3.1.0) hexane derivatives as modulators of dopamine d3 receptors
05/14/2009US20090124625 Novel alkynyl derivatives as modulators of metatropic glutamate receptors
05/14/2009US20090124001 9-amino-acridine derivatives and their use for eliminating misfolded proteins
05/14/2009US20090123423 Hydroxyamic analogs as hepatitis c virus serine protease inhibitor
05/14/2009CA2704222A1 Cyclic urea inhibitors of 11.beta.-hydroxysteroid dehydrogenase 1
05/13/2009EP2058308A1 Benzimidazoledihydrothiadiazinone derivatives used as fructose-1,6-biphosphatase inhibitors and pharmaceutical compositions containing same.
05/13/2009EP2057157A2 2-amido-4-isoxazolyl thiazole compounds exhibiting atp-utilizing enzyme inhibitory activity, and compositions, and uses thereof
05/13/2009EP2057153A1 (3-aryl-piperazin-1-yl), (2-aryl-morpholin-4-yl) and (2-aryl- thiomorpholin-4-yl) derivatives of 6,7-dialkoxyquinazoline, 6,7- dialkoxyphtalazine and 6,7-dialkoxyisoquinoline
05/13/2009EP2057146A1 Compounds and compositions as protein kinase inhibitors
05/13/2009EP2057141A1 Pyrimidone compounds as gsk-3 inhibitors
05/13/2009EP2057140A1 Morpholino pyrimidine derivatives useful in the treatment of proliferative disorders
05/13/2009EP2057135A1 Insecticidal n-substituted (2- sudstituted-1,3-thiazol) alkyl sulfoximines
05/13/2009EP2057128A2 Therapeutic substituted hydantoins and related compounds